Immunotherapies, including immune checkpoint inhibitors, have emerged as promising treatments for advanced cancers. However, a subset of patients exhibits resistance to such therapies, and the precise ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback